January Webinar * Cancun Boot Camp * Medscape CE/CME Video
14th National Conference
Publishing Opportunities *
Ottawa Blood Disease Centre Survey
Anticoagulant Therapy for Symptomatic
Calf Deep Vein Thrombosis (CACTUS)
Wednesday, January 11
2:00 pm -- 3:00 pm (EST)
In this webinar we'll examine the results of a new study on the efficacy and safety of anticoagulant treatment of acute symptomatic DVT of the calf. The research, published in December 2016, used a randomized, double-blind, placebo-controlled trial to assess whether therapeutic anticoagulation is superior to placebo.
You can read an abstract of the study
Speaker: Marc Carrier, MD, The Ottawa Hospital Research Institute
Adam Cuker, MD, University of Pennsylvania
Diane Wirth, ANP, Grady Memorial Hospital
Sara Vazquez, PharmD, University of Utah
AC Forum's Lunch & Learn Webinars are free and open to all healthcare professionals.
6th Regional AC Forum Bootcamp
January 26-27, 2017
Westin Resort & Spa, Cancun
Small-group learning, CE credit, expert faculty featured
It's not too late to register for our first international boot camp! AC Forum is partnering with Sociedad Mexicana de Trombosis y Hemostasia (SOMETH) to host this compact 2-day meeting. The comprehensvie
curriculum covers the essential aspects of anticoagulation, disease state, and drug management. Engaging discussion around quality improvement, new agents and special situations will benefit all practitioners. Join practitioners from Mexico and abroad for daily international "chalk talks."
Online CE/CME Activity for Point-of-Care Testing
Medscape is offering a free CE/CME online webinar on point-of-care testing and has tapped the expertise of AC Forum board and advisory board members. AC Forum founder Jack Ansell moderates the 30-minute discussion with board members Dan Witt and Michael Streiff and advisory board member Lynn Oertel. Topics covered include the challenges of warfarin and traditional INR monitoring, point-of-care testing and practical strategies for increasing the effectiveness of point-of-care testing.
14th National Conference in April, 2017
Spaces Limited for Master Classes and Meet the Expert Breakfast
Join us this April for
, our national conference in
Los Angeles, CA, April 20-22, 2017
. The 3-day symposium will bring together medical professionals in fields ranging from cardiology and hematology to pharmacy and family medicine for discussions on current research and evidence-based practices in the field of antithrombotic therapy.
Presentation topics include anticoagulation clinics in the future, DOACs in special populations, bridging updates, safe transitions of care, reversal agents, and more.
In addition to presentations by leading experts, the conference will feature small, topic-specific master classes,
a "meet the expert" breakfast, poster session and industry exhibits. Space is limited for the master classes and breakfast, so register now while there's still space!
For more information and to register
New Publishing Opportunities For AC Forum Members
The Anticoagulation Forum, in collaboration with the Journal of Thrombosis and Thrombolysis, is pleased to offer more publication opportunities for its community. Members are encouraged to submit original research and reviews within related areas of thrombosis, hemostasis, and vascular disease. Submissions will undergo an expedited peer-review process by the Journal's editorial team and, if accepted, will be featured in a special section of the Journal. Additionally, all authors who publish in the Journal of Thrombosis and Thrombolysis will receive a shareable link to a view-only version of their article. Submissions are welcome throughout the year by selecting the article type "Anticoagulation Forum" in Editorial Manager.
For more information about the journal and the submission instructions, please visit the Journal of Thrombosis and Thrombolysis website at www.springer.com/11239.
Physicians Wanted for DOAC Reversal Survey -- Ottawa Blood Disease Centre
The Ottawa Blood Disease Centre is conducting a survey on the evaluation and management of DOAC-associated life-threatening bleeding. Physicians are asked to participate in a brief survey using the link below:
The survey will take approximately 10 minutes to complete, and will include questions regarding demographic information, knowledge of DOAC pharmacokinetics and laboratory assessment of DOAC anticoagulation status, knowledge surrounding the assessment and management of DOAC-associated life-threatening bleeding, as well as opinions surrounding DOAC-associated life-threatening bleeding.